Memory Treatment Centers, a leading neurocognitive disease clinic, is proud to be one of the first medical organizations in the United States to offer the innovative Alzheimer’s drug Leqembi (lecanemab-irmb).
Bonita Springs, FL February 6, 2023 - Last week, Memory Treatment Centers (MTC) became amongst the very first healthcare organizations within the United States to successfully begin administering Leqembi to qualified patients at its facilities. As a recently FDA-approved disease-modifying…Read More
Memory Treatment Centers Applauds U.S. FDA Approval of Leqembi (Lecanemab)
BONITA SPRING, FL, January 10, 2023 — Memory Treatment Centers are pleased to announce that the Food and Drug Administration (FDA) has approved Lecanemab, a new drug for the treatment of Alzheimer's disease. This is an important milestone in the fight…Read More
Memory Treatment Centers is One of First to Administer Aduhelm Alzheimer’s Infusion
SALT LAKE CITY, Aug. 9, 2021 /PRNewswire/ -- Memory Treatment Centers, a PURE Healthcare company (PURE), is excited to announce the completion of their first Aduhelm infusion. Memory Treatment Centers are among the first organizations to administer the new FDA approved Alzheimer's drug,…Read More